Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.7154
Delayed Data
As of Aug 11
 -0.0096 / -1.32%
Today’s Change
0.49
Today|||52-Week Range
2.77
-45.80%
Year-to-Date

Today’s Trading

Previous close0.73
Today’s open0.72
Day’s range0.71 - 0.74
Volume62,002
Average volume (3 months)7,538,801
Market cap$105.7M
Data as of 3:59pm ET, 08/11/2020

Growth & Valuation

Earnings growth (last year)+50.64%
Earnings growth (this year)+51.07%
Earnings growth (next 5 years)+39.90%
Revenue growth (last year)-1.81%
P/E ratioNM
Price/Sales10.33
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...-0.19-4.48%
AIMAIM ImmunoTech Inc-0.31-10.26%
MRKRMarker Therapeutics ...-0.21-9.81%
ZSANZosano Pharma Corp-0.09-5.66%
Data as of 3:59pm ET, 08/11/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.5M
Annual profit (last year)-$82.8M
Net profit margin-872.95%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts